- Journalists Shed Light on Deadly Hantavirus Outbreak and a Crisis in the Nation’s ERs
- Is the horizon still bright for orthodontists?
- The Make America Healthy Again Movement Comes for Hospital Food
- What’s driving physicians to early retirement
- Why Tenet’s CEO says ASCs keep choosing USPI
- 12 recent hospital, health system president exits
- Hospitals embrace rapid opioid treatment in fentanyl era: Study
- Texas systems open 200-bed behavioral health center
- 32 health systems spending $5B on cancer care
- Sanford, North Memorial planned combination adds to Minnesota healthcare deal wave
- Lone Peak Dental Group acquires Arizona practice
- Inside Northwestern Medicine’s battle against surgeon burnout
- UT Austin launches Epic ahead of new academic medical center
- Ohio system names COO
- Buy, sell or fight: The new calculus of health system growth
- OpenAI’s growing healthcare footprint
- Tennessee optometrist pleads guilty to $6.9M Medicare fraud
- Why Cook County Health’s Medicaid coverage loss strategy is drawing attention
- Akron Children’s chosen for former Ohio college campus site
- Surgery Partners doubles down on orthopedics, robotics as total joint growth hits 14.6%
- The growing war over Anthem’s out-of-network penalty policy
- 3 PDS Health headlines to know in 1 week
- Remarks at the Conference on Financial Market Regulation
- Could ASCs help cardiology move past its ‘breaking point’?
- 3 programs expanding the anesthesia workforce in 2026
- Dad Jokes: Remarks at the 13th Annual Conference on Financial Markets Regulation
- UVM Health targets $300M in cuts, outpatient overhaul amid $280M deficit
- Maine behavioral health provider cites industry pressures in merger
- Dentists opening practices in 1 month
- The Aspen Group names new chief commercial officer
- RFK Jr. Launches Plan To Curb Antidepressant 'Overprescription'
- Georgia mental health provider adds after-hours outpatient program
- AI-augmented behavioral health provider Theris launches out of stealth
- 5 data breaches, settlements impacting cardiology
- Maine hospital adds stroke prevention, cardiac imaging services
- As new tech, AI sweeps the marketing world, Eversana Intouch’s new CEO is ‘comfortable in the gray’
- Sanford Health unveils deal to integrate Minnesota-area North Memorial Health, invest $600M
- Trump plans to fire FDA chief Marty Makary: report
- Trump plans to fire FDA chief Marty Makary: report
- Oregon governor signs behavioral health workforce expansion bills amid shortage
- Remarks at the Special Competitive Studies Project AI+ Expo
- Lawmakers, former FDA leaders and more rally behind mifepristone as Supreme Court weighs telemedicine access to abortion pill
- 5 DSOs making headlines
- Plant-Based Foods May Help Lower Risk of High Blood Pressure
- The ACA exchanges dominated Q1 earnings calls. Here's what payer, health system execs had to say
- Targeted Protein Degradation and Novel Modalities: Getting on the Frontline
- Gilead cranks up Yeztugo first-year sales forecast to $1B on 'unprecedented launch trajectory'
- Capricor Therapeutics files breach-of-contract lawsuit against US partner NS Pharma
- Op-ed: It's time to make more strategic bets on AI in healthcare
- Daiichi Sankyo takes $610M profit hit linked to ADC manufacturing overbuild
- Super Shoes Might Increase Risk Of Running Injuries, Study Says
- TV, Movies Offer Flawed Depictions Of Autism, Add To Delayed Diagnosis, Study Says
- Opioid OD Survivors Have Triple Rate Of Repeat Overdoses Than Previously Estimated
- Revisiting Pharma’s tariff reality
- A New Medicare Option For Weight Loss Drugs: What Older Americans Should Know
- Exposure Therapy Can Successfully Ease Peanut Allergies
- Listen: A Federal Agency Is After Workers’ Health Data, and Critics Are Alarmed
- In California Governor Race, Single-Payer Is a Litmus Test. There’s Still No Way To Pay for It.
- AbbVie’s Skyrizi beats out J&J’s Tremfya in April drug ad spending leaderboard
- Johnson & Johnson launches ‘Generation Fine’ depression project
- Pre-launch efforts linked to lasting drug awareness edge: report
- GSK tees up a Modern Family for meningitis messaging
- NYC invests $12M in overdose recovery workforce
- Aspen Dental to pay $2M to settle allegations of violating corporate dentistry laws
- Texas dental practice relocates into 6K-square-foot facility
- Medit launches global orthodontics division, acquires California training institute
- Pennsylvania enacts dental faculty bill
- Cruise Ship Hantavirus Outbreak Kills 3 as WHO Says Risk Is Low
- How policy, reimbursement incentives, could help healthcare address its climate footprint
- Remarks at the 13th Annual Conference on Financial Market Regulation
- 5 best practices for financially integrating behavioral health
- Fierce Pharma Asia—Summit’s surprise interim trial miss; UCB’s $2B Candid buy; J&J’s CAR-T cuts
- Amazon Pharmacy to offer home delivery for Novo Nordisk's Ozempic pill
- New York expands behavioral health data access in EHRs
- Staffing firm Cross Country Healthcare to be acquired by Knox Lane for $437M
- New Hampshire to receive $29.5M in Purdue opioid settlement
- Behavioral health leaders counter HHS ‘overprescribing’ narrative
- Clover Health's MA membership grows 51% year-over-year
- New Study Suggests The Brain Can Continue Learning While In An Unconscious State
- Health Tech Weekly Rundown: Tether rolls out medical AI for phones, wearables; Medaptus launches operational ‘command center’
- Pennsylvania sues Character.ai over AI chatbot allegedly presenting itself as licensed medical professional
- Angelini finds Catalyst for its US growth ambitions with $4.1B buyout
- FDA to reconsider shock rejection of cell therapy Ebvallo. Could uniQure be next?
- Every 1,000 Steps After Surgery Cuts Complication Risk, Study Finds
- Bullying and Politics Fuel Suicide Risk for LGBTQ+ Teens and Young Adults, Survey Finds
- Head Impacts May Disrupt Gut Health Even Without Concussion
- Class of Migraine Drug, CGRP Inhibitors, Has Added Benefit: Reduced Glaucoma Risk
- States Eye Aid to Prop Up Distressed Hospitals Amid Federal Medicaid Cuts
- That Discount at the Pharmacy Counter May Pack Hidden Costs
- Trump Promised Cheaper Drugs. Some Prices Dropped. Many Others Shot Up.
- Hims & Hers debuts its first AI care agent to interpret biomarker lab results
- Alnylam rebuked by FDA over efficacy claims on Amvuttra website
- Insulet CEO details ‘Scrubs’ device promotion win as it boosts awareness, education drive
- Oscar Health's profit hits $679M, membership rises in Q1
- Joint Commission, NACHC partner on training, new accreditation for community health centers
- Ardent Health touts outpatient growth, checked labor spend during hectic Q1
- FDA Authorizes Fruit-Flavored Vapes for Adults
- Sanofi asks to pull Tzield bid from FDA's controversial CNPV program: report
- FDA rolls out 1-day assessment pilot in bid to refocus inspection resources
- Nearly 8 in 10 employers say GLP-1 coverage drives up benefit costs: Business Group on Health
- Edibles + Alcohol Combo Poses Driving Risks Missed by Sobriety Tests
- Leapfrog Group's latest safety grades have far fewer low scores since removal of non-participating hospitals
- VR Training Helps Autistic People Navigate Police Encounters
- Novo CEO cites pricing 'sweet spot' as Wegovy pill debuts with $355M quarter
- Weight Loss Surgeries Fall More Than 20% As Patients Turn To GLP-1 Meds, Experts Say
- FDA blocks publication of COVID, shingles vaccine safety studies: NYT
- Bayer diagnoses how to build trust in cell and gene therapies
- Amwell boasts higher than expected renewals, retention despite Q1 revenue decline
- First Psych Ward Stay Signals Long-Term Mental Health Struggles For Nearly All Patients
- Why Melatonin Shouldn't Be A Bedtime Go-To For Kids
- Children Living Near Gas Stations Have Higher Cancer Risk, Study Finds
- The timing is right for psychedelics manufacturer Optimi Health's IPO
- HHS' Healthy Food Agenda Puts Hospitals On Notice About Patients' Meals
- A New Medicare Option for Weight Loss Drugs: What Older Americans Should Know
- Trump’s Drug Strategy Aims To Bolster Addiction Services — Despite Gutting of Government Support
- Inside the gaps in fertility and surrogacy systems
- CVS execs say company on track to meet MA margin goals by 2028
- Facilitating Access to Trump Accounts
- Fixing Failures to Communicate
- Hinge Health lifts 2026 outlook after strong Q1 as it expands to new conditions
- For nonprofit hospitals, pricey management consultants haven't yielded better performances: study
- Supreme Court Issues Stay, Keeping Abortion Pill Mifepristone Available by Mail For Now
- Statement on Proposing Release for Semiannual Reporting
- Quarterly Questions: Statement on the Proposed Amendments to Allow Semiannual Reporting
- Statement on Proposing Semiannual Reporting
- Wellstar partners with BD to implement AI-driven medication management system
- Listen to the Latest ‘KFF Health News Minute’
- Newer Migraine Drugs Reduce Headache Days With Fewer Side Effects
- New Drug Combo Effective Against Treatment-Resistant IBD, Trials Show
- New Warning Labels Might Help People Cut Back On Drinking
- Ozempic Can Curb Cravings in Alcohol Use Disorder, Landmark Trial Finds
- US on the Brink of Losing Measles-free Status, Study Warns
- Delays in Visa Program Threaten Doctor Placements in Underserved Areas
- States Eye Aid To Prop Up Distressed Hospitals Amid Federal Medicaid Cuts
- Supreme Court Puts Brakes on Abortion Pill Restrictions
- FDA Green Lights Expanded Access to Pancreatic Cancer Drug, Daraxonrasib
- Online Misinformation Adding To Americans' Skin Cancer Risk, Survey Finds
- Medtronic’s Updated Mitral Valve, Mosaic Neo, Gets FDA approval
- Medtronic’s Updated Mitral Valve, Mosaic Neo, Gets FDA approval
- Social Media Videos, Easy Access Raise Risk of Teen Inhalant Use
- Staff Statement Regarding Pooled Employer Plans
- Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
- Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
- Edwards Lifesciences Shares Ten-Year Pivotal Data Supporting Long-Term Durability of Resilia Tissue
- Edwards Lifesciences Shares Ten-Year Pivotal Data Supporting Long-Term Durability of Resilia Tissue
- 'Fitspirational' Posts Can Be More Harmful Than Motivational, Review Concludes
- Parents’ Stress Tied to Children’s Mental Health, New Survey Finds
- Surgeon Multitasking Increases Death Risk Of Organ Transplantees
- When Natural Disasters Strike, Another Crisis Hits Those Recovering From Opioid Addiction
- FDA Recalls Several Ghirardelli Powdered Beverages Over Potential Contamination
Prepare for more hospital charges and insurance premium hikes.
Mandates have that effect, and much more.
What are the moral implications of requiring hospitals to offer IUDs to "certain patients"? Does this refer to Medicaid patients? If so, is such discrimination constitutional?
Thursday, September 26, 2024 1:30 p.m.
AGENDA
SB 973 Sen. Cavanagh Insurance; health insurers; coverage for certain contraception; require.
SB 974 Sen. Irwin Human services; medical services; coverage for contraception and emergency contraception; require.
SB 987 Sen. McMorrow Insurance; health insurers; coverage for inpatient long-acting reversible contraceptives; require.
SB 988 Sen. McMorrow Human services; medical services; coverage for immediate postpartum intrauterine devices and contraceptive implants and associated anesthesia services; provide for.
SB 1006 Sen. McMorrow Health facilities; hospitals; hospitals stocking intrauterine devices; require and require hospitals to offer intrauterine devices to certain patients.
And any other business properly before the committee.
Michigan Senate Bill 1006 requires that Maternity Wards of all religious affiliations stock and provide contraceptives to desiring patients.
A hospital that operates a maternity unit shall ensure that an individual who is giving birth in the hospital has the option, if not medically contraindicated, of having an intrauterine device implanted after delivery and before the individual is discharged. A hospital shall ensure that a sufficient number of intrauterine devices are in stock and available at the hospital to meet the requirements of this section.
https://www.legislature.mi.gov/documents/2023-2024/billintroduced/Senate/pdf/2024-SIB-1006.pdf
The short Bill, which was supported in its Health Policy committee meeting this past Thursday, makes no exemption for Catholic Hospitals which might have a religious dispute with furnishing contraceptives to patients. This may prove to create a dispute between the Legislature and religiously affiliated Healthcare Systems.
Meeting Notes for Thursday's committee: https://committees.senate.michigan.gov/committees/ViewDocument/?apn=2023_2024_session%2Fcommittee%2Fsenate%2Fstanding%2Fhealth_policy%2Fmeetings%2F2024-09-26-1%2Fdocuments%2Ftestimony%2FAmy%20Zaagman%20MCMCH%20Support%20SBs%20973%20974%20987%20988%201006.pdf
Lest we forget the breast cancer implications here, the risk was reiterated last week.
MedPage reports JAMA's publication of a recent Danish study.
Methodology is clipped for length, but worth reading.
https://www.medpagetoday.com/hematologyoncology/breastcancer/112451
Hormonal IUDs Linked to Increased Breast Cancer Risk
— Absolute risk remains low, however
During follow-up of almost 7 years, hormone-releasing IUD use conferred a 40% higher risk of breast cancer. The data showed a trend toward increasing risk with duration of IUD use, reaching 80% among women who reported using the devices for 10-15 years.
The differences translated into excess breast cancer diagnoses that ranged from 14 to 71 per 10,000 users, although a trend analysis proved to be nonsignificant, reported Lina Steinrud Mørch, PhD, of the Danish Cancer Institute in Copenhagen, and co-authors in JAMA.
"Given the increase in LNG-IUS [levonorgestrel intrauterine systems] among females at an age with some risk for breast cancer, and its likely long-term use, information about breast cancer risk should accompany discussions about benefits and risks," the authors stated. In a prior study, "the HR [hazard ratio] with short-term LNG-IUS use was similar to that of contraceptive pills (1.2, 95% CI 1.1-1.3)."
But that earlier research could not address the duration of continuous use, and prior studies have not adequately accounted for use of other types of hormonal contraceptives.
The new results add to existing evidence suggesting an association between hormonal contraception and breast cancer, and are consistent with a recent study showing a 29% greater relative risk for breast cancer among BRCA1 carriers who used any type of hormonal contraceptive.
To examine breast cancer risk by duration of LNG-IUS use, Mørch and colleagues queried Danish national healthcare registries to identify first-time users of LNG-IUS, ages 15-49, during 2000-2019. Users of other hormonal contraceptives within the previous 5 years were excluded.
The search identified 78,595 new users of LNG-IUS who were matched to 78,595 non-users of hormonal contraceptives. The study population had a mean age of 38. Mean duration of follow-up was 6.8 years for the entire population, including 5.9 years for the LNG-IUS users and 7.7 years for the non-users.
<clip>
It seems Gov. Whitmer was not content with the legislature's pace on these bills.
Yesterday, several news sources broke the news of her executive order mandating insurance cover birth control pills, even the over-the-counter kinds.
Quoting Fox 17 News here. MLive's story is behind paywall.
Michigan to roll out free contraceptives program next month
The state of Michigan is launching a new program in November that will guarantee free access to contraception.LANSING, Mich. — The state of Michigan is launching a new program in November that will guarantee free access to contraception.
The “Take Control of Your Birth Control” program allows participating community partners and federally qualified health centers the ability to distribute free condoms, birth control and emergency contraception to Michiganders.
Recipients will also be given information that will enable them to make informed decisions on their reproductive health.
“We always want people to know what health resources that are available, especially if health options are available for free or low cost. I think it's our duty to really educate them,” says Dr. Natasha Bagdasarian, chief medical executive at the Michigan Department of Health and Human Services. “It's our role to really make sure that people have the best information possible so that they can make decisions about their health and their bodies that work for them.”
The program lasts through November.
The state expects to publish a full list of participating organizations — and an interactive map of their locations — on its website before next Friday.
Marquette WLUC's Colin Jackson included a detail not reported elsewhere:
"Contraceptive items will be distributed until supplies run out."
Fascinating thought.
One wonders how he reached it. Because it's spelled out in the EO?
Because everyone knows this market challenge will cause shortages?
Or - ??
Back in August, Michigan Public's Tracy Samilton reported some of the back room dealing on these bills.
Importantly, mandating insurance coverage for over the counter birth control negates competitive price drops.
Expect health insurance rates to rise, since this also returns cost burden to insurance premiums and taxpayers.
New state Senate bills would expand insurance coverage of birth control
Bills introduced this week (SB 973, SB 974) in the state Senate would expand what kind of birth control health insurance plans in Michigan would be required to cover.
Federal law requires Medicaid and nearly all private health insurance plans to cover many kinds of contraceptive drugs requiring a prescription, without copays -- but not over the counter types of birth control like the recently approved Opill, or the emergency contraception drug Plan B.
New bills introduced in the state Senate would require Michigan health insurance plans to cover these over-the-counter birth control drugs as well.
The Michigan Association of Health Plans says it supports maintaining access to contraceptive drugs — while it plans to work with the bills' sponsors to better understand the intent of the bills, and evaluate their impact on health insurance cost and affordability.
Meanwhile, these bills (and more) are still on this committee's action list. They might be worth a conversation next time you see a legislator.
One day before Gov. Whitmer's announced free BCP, the Biden Administration proposed a federal rule to do the same thing. Coordinated? Or one-upmanship?
In Michigan, of course, taxpayers actually pick up the tab. In this case, funds from MDHHS's family planning budget, which the legislature expanded this year by 5.6M.
In Washington's plan, we'll still be picking up the tab, just with a larger bureaucracy. On the plus side, the feds operate under rulemaking procedures, and the public comment period is open. Anyone concerned about this can give their two cents.
Morning Brew reported the DC side of the story.
White House wants to make over-the-counter birth control free
Insurers might be required to offer full coverage of OTC birth control pill and other contraceptives.
By Sam Klebanov | October 22, 2024The Biden administration unveiled a proposed rule yesterday that would require private insurers to pick up the tab for all prescriptionless birth control.
Insurance companies are already mandated to offer 100% coverage of some prescription contraceptives (thanks, Obamacare), but the 2010 law doesn’t address over-the-counter birth control pills, which only recently arrived in the US.
Removing barriers to birth control
The FDA approved an OTC birth control pill, Opill, for the first time last year. But Opill sells for $19.99 per month, so many women with private insurance looking for free access to birth control may not be able to get it. The same often goes for prescribed contraceptives: Reproductive rights activists say that some of the latest birth control methods that are associated with fewer side effects aren’t 100% covered by many insurance plans.
Biden’s rule aims to fix this by also requiring insurers to fully cover a greater variety of IUDs and other products that may appear in a sex-ed curriculum.
Looking ahead: The birth control access push comes just two weeks before the presidential election, in which family planning has been a major flashpoint. The next White House occupant will get to decide whether the proposal goes into effect.
Finally, readers will recall that pharmacist-prescribing or "almost over the counter" was proposed for the same drug not long ago.
The third leg of the state-federal-industry tango showed up in a bill package posted here six months ago
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.













